Aptevo Therapeutics Statistics

Total Valuation

APVO has a market cap or net worth of $5.37 million. The enterprise value is $2.45 million.

Market Cap	5.37M
Enterprise Value	2.45M

Important Dates

The last earnings date was Thursday, November 7, 2024, before market open.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

APVO has 18.51 million shares outstanding. The number of shares has increased by 1,417.44% in one year.

Current Share Class	18.51M
Shares Outstanding	18.51M
Shares Change (YoY)	+1,417.44%
Shares Change (QoQ)	+199.68%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	1.76%
Float	17.57M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.12
P/TBV Ratio	1.21
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.70, with a Debt / Equity ratio of 1.09.

Current Ratio	1.70
Quick Ratio	1.32
Debt / Equity	1.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -250.96% and return on invested capital (ROIC) is -104.10%.

Return on Equity (ROE)	-250.96%
Return on Assets (ROA)	-72.75%
Return on Capital (ROIC)	-104.10%
Revenue Per Employee	n/a
Profits Per Employee	-$593,025
Employee Count	40
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -96.53% in the last 52 weeks. The beta is 5.06, so APVO's price volatility has been higher than the market average.

Beta (5Y)	5.06
52-Week Price Change	-96.53%
50-Day Moving Average	0.22
200-Day Moving Average	1.55
Relative Strength Index (RSI)	56.43
Average Volume (20 Days)	3,239,422

Short Selling Information

The latest short interest is 1.20 million, so 6.49% of the outstanding shares have been sold short.

Short Interest	1.20M
Short Previous Month	154,732
Short % of Shares Out	6.49%
Short % of Float	6.84%
Short Ratio (days to cover)	0.09

Income Statement

Revenue	n/a
Gross Profit	-16.89M
Operating Income	-24.60M
Pretax Income	-24.95M
Net Income	-23.72M
EBITDA	-24.21M
EBIT	-24.60M
Earnings Per Share (EPS)	-$8.50

Full Income Statement

Balance Sheet

The company has $7.75 million in cash and $4.83 million in debt, giving a net cash position of $2.92 million or $0.16 per share.

Cash & Cash Equivalents	7.75M
Total Debt	4.83M
Net Cash	2.92M
Net Cash Per Share	$0.16
Equity (Book Value)	4.42M
Book Value Per Share	0.26
Working Capital	4.13M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-23.28M
Capital Expenditures	n/a
Free Cash Flow	-23.28M
FCF Per Share	-$1.26

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

APVO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,417.44%
Shareholder Yield	-1,417.44%
Earnings Yield	-441.85%
FCF Yield	-433.62%

Analyst Forecast

The average price target for APVO is $8.00, which is 2,658.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.00
Price Target Difference	2,658.62%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 6, 2024. It was a reverse split with a ratio of 0.0227273:1.

Last Split Date	Mar 6, 2024
Split Type	Reverse
Split Ratio	0.0227273:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1